The FirstCyte Breast Test, which encompasses ductal lavage, is currently used as a risk assessment tool for women who are at high risk for breast cancer. Cells collected via the FirstCyte Breast Test are used to detect atypical changes in cells lining the milk ducts, where an estimated 95 percent of all breast cancers originate.

By identifying high risk women who have abnormal cells in their milk ducts and who are apparently at highest risk for developing breast cancer, the FirstCyte Breast Test assists in decision making about appropriate preventative measures.

The FirstCyte Breast Test is currently being performed by trained obstetrician/gynecologists, radiologists and breast surgeons and is used in conjunction with mammography, clinical exams, breast self-exams and other standard breast cancer detection methods.